Details of the Drug

General Information of Drug (ID: DMW3YKM)

Drug Name

JointStem

Indication

Disease Entry	ICD 11	Status	REF
Knee osteoarthritis	FA01	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04368806) A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee Osteoarthritis. U.S.National Institutes of Health.